BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14180255)

  • 21. EVALUATION OF A NEW PROGESTIN.
    CROWSON LB; WINER BA; NOYES RW
    Obstet Gynecol; 1965 Sep; 26():349-55. PubMed ID: 14341200
    [No Abstract]   [Full Text] [Related]  

  • 22. ORAL CONTRACEPTIVES AND CORONARY THROMBOSIS.
    LLOYD G
    Br Med J; 1965 Feb; 1(5434):587-8. PubMed ID: 14243067
    [No Abstract]   [Full Text] [Related]  

  • 23. THROMBOEMBOLISM IN PATIENTS RECEIVING PROGESTATIONAL DRUGS.
    REED DL; COON WW
    N Engl J Med; 1963 Sep; 269():622-4. PubMed ID: 14044401
    [No Abstract]   [Full Text] [Related]  

  • 24. PROGESTERONE.
    CAREY HM
    Mod Trends Hum Reprod Physiol; 1963; 15():92-112. PubMed ID: 14115169
    [No Abstract]   [Full Text] [Related]  

  • 25. WHAT ARE THE DANGERS OF ORAL CONTRACEPTION?
    SWYER GI
    Proc R Soc Med; 1964 Mar; 57(3):210-2. PubMed ID: 14130875
    [No Abstract]   [Full Text] [Related]  

  • 26. CHLORMADINONE, A POTENT SYNTHETIC ORAL PROGESTIN: EVALUATION OF 1002 CYCLES.
    BALIN H; WAN LS
    Int J Fertil; 1965; 10():127-36. PubMed ID: 14291546
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE METHANISM OF THE OVULATION-INHIBITING EFFECT OF ORAL PROGESTAGENS].
    SAS M; KOVACS L; NEMETH I; SZONTAGH FE
    Endokrinologie; 1964 Feb; 46():58-64. PubMed ID: 14184333
    [No Abstract]   [Full Text] [Related]  

  • 28. [DATA ON THE MECHANISM OF THE OVULATION INHIBITING EFFECT OF ORAL PROGESTATIONAL HORMONES].
    SAS M; KOVACS L; NEMETH I; SZONTAGH F
    Orv Hetil; 1964 Jun; 105():1125-7. PubMed ID: 14160761
    [No Abstract]   [Full Text] [Related]  

  • 29. THE DIFFICULTIES AND DANGERS OF ORAL CONTRACEPTION.
    MILLS WG
    Proc R Soc Med; 1964 Mar; 57(3):207-10. PubMed ID: 14130874
    [No Abstract]   [Full Text] [Related]  

  • 30. [APROPOS OF THE OVULATION-INHIBITING DOSAGE OF ORAL GESTAGENS].
    SZONTAGH FE; SAS M
    Zentralbl Gynakol; 1964 Mar; 86():410-2. PubMed ID: 14198198
    [No Abstract]   [Full Text] [Related]  

  • 31. THE EFFECT OF SYNTHETIC PROGESTOGENS ON THE OVARIES.
    TOTH F
    Int J Fertil; 1964; 9():151-3. PubMed ID: 14106249
    [No Abstract]   [Full Text] [Related]  

  • 32. [CONSIDERATIONS ON SYNTHETIC PROGESTOGENS].
    DE LIMA GR
    Matern Infanc (Sao Paulo); 1963; 22():499-528. PubMed ID: 14166316
    [No Abstract]   [Full Text] [Related]  

  • 33. [EFFECT OF SYNTHETIC GESTAGENS ON THE VAGINAL EPITHELIUM].
    TOTH F
    Cesk Gynekol; 1964 Feb; 29():19-20. PubMed ID: 14142653
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE PROGESTOGENS DERIVED FROM NORTESTOSTERONE: INDICATIONS AND CONTRA-INDICATIONS IN WOMEN. 1].
    MULLER P
    Strasb Med; 1965 Apr; 16():287-308 CONTD. PubMed ID: 14331389
    [No Abstract]   [Full Text] [Related]  

  • 35. THE INFLUENCE OF CERTAIN STEROIDS ON THE SERUMBILIRUBINCONCENTRATION OF HOMOZYGOUS GUNN-RATS.
    VAN LEUSDENH
    Bull Soc R Belge Gynecol Obstet; 1964; 34():15-24. PubMed ID: 14185717
    [No Abstract]   [Full Text] [Related]  

  • 36. [SYNTHETIC PROGESTOIDS IN GYNECOLOGY].
    SALOMON Y
    Gaz Med Fr; 1964 Oct; 71():3089-104. PubMed ID: 14213250
    [No Abstract]   [Full Text] [Related]  

  • 37. [BLOCK OF OVULATION AND BLOCK OF NIDATION].
    CIULLA U
    Riv Ostet Ginecol Prat; 1964 May; 46():393-400. PubMed ID: 14171510
    [No Abstract]   [Full Text] [Related]  

  • 38. ORAL CONTRACEPTION.
    MORRIS N
    Practitioner; 1965 Apr; 194():478-84. PubMed ID: 14273194
    [No Abstract]   [Full Text] [Related]  

  • 39. CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES.
    MEARS E
    Proc R Soc Med; 1964 Mar; 57(3):204-7. PubMed ID: 14130873
    [No Abstract]   [Full Text] [Related]  

  • 40. PROGESTOGENS TODAY.
    MACDONALD RR
    Practitioner; 1964 Jan; 192():158-65. PubMed ID: 14106647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.